| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 1,911,724 | 1,883,109 | 2,096,337 | 1,984,641 | | Cost of Revenue | 1,446,162 | 1,426,565 | 1,569,870 | 1,501,064 | | | Gross Profit | 465,562 | 456,544 | 526,467 | 483,577 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 438,063 | 430,288 | 480,407 | 442,649 | | Non Recurring |
-
| 456,973 | 727,597 | 943,493 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,499 | (430,717) | (681,537) | (902,565) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,089 | 9,863 | 3,293 | 21,770 | | Earnings Before Interest And Taxes | 40,588 | (420,854) | (678,244) | (880,795) | | Interest Expense | 19,348 | 24,497 | 29,822 | 29,642 | | Income Before Tax | 21,240 | (445,351) | (708,066) | (910,437) | | Income Tax Expense | 8,210 | (41,000) | (276,416) | (16,319) | | Minority Interest | 889 | 9,178 | (232) | (102) | | | | Net Income From Continuing Ops | 13,919 | (395,173) | (431,882) | (894,220) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,919 | (395,173) | (431,882) | (894,220) | | Preferred Stock And Other Adjustments | (772) | (824) | (812) | (1,052) | | | Net Income Applicable To Common Shares | $13,147 | ($395,997) | ($432,694) | ($895,272) |
|
0.45% Nasdaq 
0.20%
Income Statement
